文献速递其他结缔组织病血管炎

灾难性抗磷脂综合征中周围大血管血栓形成的描述性分析:来自CAPS注册研究

Peripheral macrovascular thrombosis in catastrophic antiphospholipid syndrome (CAPS): A descriptive analysis from the "CAPS Registry".
PubMed 文献 · Semin Arthritis Rheum · 2026-09-13

基于国际CAPS注册研究843例患者的回顾性横断面分析,发现280例(33.2%)发生周围大血管血栓形成,以静脉事件为主(58.3%),动脉事件占30.6%。周围动脉血栓形成与较高大截肢风险相关,报告28例大截肢,占周围动脉血栓形成事件的24%。

要点

  • CAPS患者中周围大血管血栓形成发生率为33.2%,以深静脉血栓为主。
  • 周围动脉血栓形成者大截肢风险高,28例大截肢占该组24%。
  • 有无周围大血管血栓形成两组间死亡率无显著差异。

核心结论

  • 周围大血管血栓形成是CAPS的临床相关表现,主要呈现为深静脉血栓形成。
  • 周围动脉血栓形成携带升高的大截肢风险,对长期发病率有实质贡献。

研究设计与样本

  • 回顾性横断面研究,使用国际CAPS注册研究数据,纳入843例患者。
  • 按有无周围大血管血栓形成对发作进行分类,比较临床表现、免疫学特征、治疗与死亡率,并进行单因素和多因素分析。

主要发现

  • 280例患者(33.2%)发生周围大血管血栓形成,事件主要为静脉性(58.3%),其次为动脉性(30.6%)和动静脉合并血栓形成(11.2%)。
  • 静脉和动脉血栓形成均主要累及下肢和近端节段。
  • 有周围大血管血栓形成的发作中,男性、CAPS作为抗磷脂综合征的首发表现、感染和恶性肿瘤作为触发因素以及肺部受累显著更常见,而死亡率在组间无显著差异。
  • 无周围大血管血栓形成的发作显示更高的系统性红斑狼疮率、三抗体阳性率、血栓性微血管病实验室特征及多器官受累。
  • 动脉血栓形成与较高年龄相关,并携带高的大截肢风险,报告28例大截肢,占周围动脉血栓形成发作的24%。

临床怎么用

  • 在CAPS患者中应关注周围大血管血栓形成,尤其表现为深静脉血栓形成时。
  • 对发生周围动脉血栓形成的CAPS患者,需警惕大截肢风险并加强监测与管理。

局限性

  • 回顾性横断面研究设计,基于注册研究数据,可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize peripheral macrovascular thrombosis in patients with catastrophic antiphospholipid syndrome (CAPS) and to analyse clinical and laboratory differences between episodes with and without peripheral macrovascular thrombosis, and between arterial and venous events. METHODS: A retrospective cross-sectional study was performed using data from the international "CAPS Registry", including 843 patients. Episodes were classified according to the presence or absence of peripheral macrovascular thrombosis. Vascular characteristics were assessed in episodes with peripheral macrovascular thrombosis, while clinical manifestations, immunological profile, treatment, and mortality were compared across study groups. Univariate and multivariable analyses were performed. RESULTS: Peripheral macrovascular thrombosis occurred in 280 patients (33.2%). Events were mainly venous (58.3%), followed by arterial (30.6%) and combined arterial-venous thrombosis (11.2%). Both venous and arterial thromboses predominantly involved the lower limbs and proximal segments. Male sex, CAPS as the first manifestation of antiphospholipid syndrome, infection and malignancy as triggers, and pulmonary involvement were significantly more frequent in episodes with peripheral macrovascular thrombosis, whereas mortality did not differ significantly between groups. Episodes without peripheral macrovascular thrombosis showed higher rates of systemic lupus erythematosus, triple antiphospholipid antibody positivity, laboratory features of thrombotic microangiopathy, and multiorgan involvement. Arterial thrombosis was associated with older age, and carried high risk of major amputation, with 28 major amputations reported, accounting for 24% of episodes with peripheral arterial thrombosis. CONCLUSION: Peripheral macrovascular thrombosis is a clinically relevant manifestation of CAPS, mainly presenting as deep vein thrombosis. Peripheral arterial thrombosis carried an elevated risk of major amputation, contributing substantially to long-term morbidity.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Vilaplana B, Russa A, Jerez A, et al. Peripheral macrovascular thrombosis in catastrophic antiphospholipid syndrome (CAPS): A descriptive analysis from the "CAPS Registry". Semin Arthritis Rheum. 2026. PMID: 42766982. doi:10.1016/j.semarthrit.2026.153076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。